Aspire Biopharma Holdings, Inc. (ASBP)
NASDAQ: ASBP · Real-Time Price · USD
1.200
+0.040 (3.45%)
At close: Mar 9, 2026, 4:00 PM EDT
1.190
-0.010 (-0.83%)
After-hours: Mar 9, 2026, 7:59 PM EDT
Aspire Biopharma Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Net Income | -20.54 | -1.31 | -0.36 | -0.6 |
| Change in Accounts Payable | 0.04 | 0.25 | 0.05 | 0.1 |
| Change in Other Net Operating Assets | 0.89 | 0.8 | 0.32 | 0.35 |
| Operating Cash Flow | -3.52 | -0.27 | 0.01 | -0.14 |
| Sale (Purchase) of Intangibles | - | - | - | -4.9 |
| Investing Cash Flow | - | - | - | -4.9 |
| Issuance of Common Stock | - | - | - | 1 |
| Other Financing Activities | -0.64 | - | - | 3.85 |
| Financing Cash Flow | 5.45 | 0.26 | - | 4.85 |
| Net Cash Flow | 1.93 | -0.01 | 0.01 | -0.19 |
| Cash Income Tax Paid | 0 | 0 | - | - |
| Levered Free Cash Flow | 16.95 | -0.68 | -0.19 | - |
| Unlevered Free Cash Flow | 16.42 | -0.62 | -0.19 | - |
| Change in Working Capital | 0.9 | 1.04 | 0.37 | 0.45 |
Source: S&P Capital IQ. Standard template.
Financial Sources.